Michael A. Shipstone

634 total citations
25 papers, 399 citations indexed

About

Michael A. Shipstone is a scholar working on Dermatology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael A. Shipstone has authored 25 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 8 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael A. Shipstone's work include Dermatology and Skin Diseases (8 papers), Veterinary Oncology Research (7 papers) and Nail Diseases and Treatments (6 papers). Michael A. Shipstone is often cited by papers focused on Dermatology and Skin Diseases (8 papers), Veterinary Oncology Research (7 papers) and Nail Diseases and Treatments (6 papers). Michael A. Shipstone collaborates with scholars based in Australia, United States and Israel. Michael A. Shipstone's co-authors include Ralf S. Mueller, Emmanuel Bensignor, Kenneth Mason, David L. Duffy, Myat T. Kyaw-Tanner, S. V. Bettenay, Lluís Ferrer, Manon Paradis, Wayne S. Rosenkrantz and Tara Paterson and has published in prestigious journals such as Journal of Heredity, Veterinary Record and Immunogenetics.

In The Last Decade

Michael A. Shipstone

23 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Shipstone Australia 12 192 161 105 88 56 25 399
Cathy Curtis United Kingdom 13 174 0.9× 97 0.6× 162 1.5× 33 0.4× 23 0.4× 21 393
Jon D. Plant United States 10 67 0.3× 178 1.1× 103 1.0× 94 1.1× 27 0.5× 14 360
Nobuo Murayama Japan 11 233 1.2× 103 0.6× 137 1.3× 26 0.3× 21 0.4× 32 420
Adam P. Patterson United States 8 58 0.3× 203 1.3× 161 1.5× 80 0.9× 32 0.6× 13 429
Leena Saijonmaa‐Koulumies United Kingdom 10 141 0.7× 109 0.7× 129 1.2× 35 0.4× 20 0.4× 15 329
Ian Mason United Kingdom 10 88 0.5× 149 0.9× 113 1.1× 92 1.0× 30 0.5× 18 323
Courtney Meason‐Smith United States 8 51 0.3× 114 0.7× 143 1.4× 37 0.4× 25 0.4× 11 281
Sandra R. Merchant United States 8 92 0.5× 18 0.1× 26 0.2× 26 0.3× 62 1.1× 17 330
Keith A. Hnilica United States 10 165 0.9× 34 0.2× 120 1.1× 6 0.1× 26 0.5× 16 387
R. Alonso Spain 9 50 0.3× 88 0.5× 47 0.4× 135 1.5× 7 0.1× 20 359

Countries citing papers authored by Michael A. Shipstone

Since Specialization
Citations

This map shows the geographic impact of Michael A. Shipstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Shipstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Shipstone more than expected).

Fields of papers citing papers by Michael A. Shipstone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Shipstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Shipstone. The network helps show where Michael A. Shipstone may publish in the future.

Co-authorship network of co-authors of Michael A. Shipstone

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Shipstone. A scholar is included among the top collaborators of Michael A. Shipstone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Shipstone. Michael A. Shipstone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shipstone, Michael A., et al.. (2021). Carbon dioxide laser surgery for chronic proliferative and obstructive otitis externa in 26 dogs. Veterinary Dermatology. 32(3). 262–262. 4 indexed citations
3.
Mueller, Ralf S., et al.. (2020). Diagnosis and treatment of demodicosis in dogs and cats. Veterinary Dermatology. 31(1). 4–4. 39 indexed citations
4.
Mackie, John T., et al.. (2017). Progressive cutaneous viral pigmented plaques in three Hungarian Vizslas and the response of lesions to topical tigilanol tiglate gel. Veterinary Medicine and Science. 4(1). 53–62. 9 indexed citations
5.
Trott, Darren J., Stephen W. Page, Sanjay Garg, et al.. (2017). In vitro comparison of the dermal penetration of three different topical formulations containing lasalocid. Veterinary Dermatology. 28(4). 342–342.
6.
Shipstone, Michael A., et al.. (2016). Canine eosinophilic granuloma of the digits treated with prednisolone and chlorambucil. Veterinary Dermatology. 27(5). 446–446. 4 indexed citations
7.
Shipstone, Michael A., et al.. (2015). Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002–2012). Veterinary Dermatology. 26(5). 345–345. 10 indexed citations
8.
Shipstone, Michael A., et al.. (2015). A small‐scale open‐label study of the treatment of canine flea allergy dermatitis with fluralaner. Veterinary Dermatology. 26(6). 417–417. 9 indexed citations
9.
Mueller, Ralf S., et al.. (2012). Treatment of demodicosis in dogs: 2011 clinical practice guidelines. Veterinary Dermatology. 23(2). 86–86. 81 indexed citations
10.
O’Leary, Caroline A., et al.. (2011). High allergen‐specific serum immunoglobulin E levels in nonatopic West Highland white terriers. Veterinary Dermatology. 22(3). 257–266. 20 indexed citations
11.
O’Leary, Caroline A., Myat T. Kyaw-Tanner, David L. Duffy, et al.. (2011). PTPN22 polymorphisms may indicate a role for this gene in atopic dermatitis in West Highland white terriers. BMC Research Notes. 4(1). 571–571. 11 indexed citations
12.
O’Leary, Caroline A., David L. Duffy, Myat T. Kyaw-Tanner, et al.. (2011). Atopic dermatitis in West Highland white terriers is associated with a 1.3-Mb region on CFA 17. Immunogenetics. 64(3). 209–217. 18 indexed citations
13.
Duffy, David L., et al.. (2011). IgE Responsiveness to Dermatophagoides farinae in West Highland White Terrier Dogs Is Associated with Region on CFA35. Journal of Heredity. 102(Suppl 1). S74–S80. 14 indexed citations
14.
Moss, Susan, et al.. (2011). Biological efficacy and stability of diluted ticarcillin–clavulanic acid in the topical treatment of Pseudomonas aeruginosa infections. Veterinary Dermatology. 23(2). 97–97. 6 indexed citations
15.
O’Leary, Caroline A., et al.. (2011). Real-time PCR quantification of the canine filaggrin orthologue in the skin of atopic and non-atopic dogs: a pilot study. BMC Research Notes. 4(1). 554–554. 8 indexed citations
16.
Kyaw-Tanner, Myat T., et al.. (2009). Haplotype sharing excludes canine orthologous Filaggrin locus in atopy in West Highland White Terriers. Animal Genetics. 40(5). 793–794. 22 indexed citations
17.
Mueller, Ralf S., S. V. Bettenay, & Michael A. Shipstone. (2002). Cutaneous candidiasis in a dog caused by Candida guilliermondii. Veterinary Record. 150(23). 728–730. 24 indexed citations
18.
Mueller, Ralf S., S. V. Bettenay, & Michael A. Shipstone. (2001). Value of the pinnal‐pedal reflex in the diagnosis of canine scabies. Veterinary Record. 148(20). 621–623. 13 indexed citations
19.
Mueller, Ralf S., et al.. (2000). Diagnosis of canine claw disease – a prospective study of 24 dogs. Veterinary Dermatology. 11(2). 133–141. 22 indexed citations
20.
Shipstone, Michael A. & Kenneth Mason. (1995). The Use of Insect Development Inhibitors as an Oral Medication for the Control of the FleasCtenocephalides felis, Ct. canisin the Dog and Cat. Veterinary Dermatology. 6(3). 131–137. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026